Christopher L. Carpenter
Private Equity Investor bij Sofinnova Investments, Inc.
Profiel
Christopher L.
Carpenter is currently an Executive Partner at Sofinnova Investments, Inc. and also serves as the Chief Medical Officer at Catamaran Bio, Inc. Previously, he held the position of Senior Vice President at GSK Plc from 2013 to 2017 and was the Chief Medical Officer at Rubius Therapeutics, Inc. from 2017 to 2020.
Carpenter received his undergraduate degree from Stanford University and his doctorate from the University of Southern California.
Actieve functies van Christopher L. Carpenter
| Bedrijven | Functie | Begin |
|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 03-01-2022 |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Corporate Officer/Principal | - |
Eerdere bekende functies van Christopher L. Carpenter
| Bedrijven | Functie | Einde |
|---|---|---|
| RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 06-01-2020 |
| GSK PLC | Corporate Officer/Principal | 01-08-2017 |
Opleiding van Christopher L. Carpenter
| Stanford University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Finance |
